1 / 78

PROBLEM OF ANTIBIOTIC RESISTANCE IN A DEVELOPING COUNTRY

PROBLEM OF ANTIBIOTIC RESISTANCE IN A DEVELOPING COUNTRY. DR.ALTAF AHMED Head of Clinical Microbiology Chairman CSSD Liaquat National Hospital, Karachi General Secretary Infectious Diseases Society of Pakistan. Antibiotic resistance in Pakistan. Epidemiology – GLOBAL/LOCAL-

sari
Télécharger la présentation

PROBLEM OF ANTIBIOTIC RESISTANCE IN A DEVELOPING COUNTRY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PROBLEM OF ANTIBIOTIC RESISTANCE IN A DEVELOPING COUNTRY DR.ALTAF AHMED Head of Clinical Microbiology Chairman CSSD Liaquat National Hospital, Karachi General Secretary Infectious Diseases Society of Pakistan

  2. Antibiotic resistance in Pakistan • Epidemiology – GLOBAL/LOCAL- • MRSA/VRE/ Pneumo/ESBL/ MDR typhoid/MDR-TB • Reasons? • WHAT CAN BE DONE?

  3. Infectious diseases still account for 45% of deaths in low-income countries and for almost one in two premature deaths worldwide. • Most of these deaths (about 90%) are due to six diseases: • acute respiratory infection (mainly pneumonia), • diarrhoeal disease, • HIV/AIDS, • tuberculosis, • malaria • measles.

  4. Use of antibiotics Where antibiotics are used Types of use Questionable use ------------------------------------------------------------------------------------ Human use (50%) 20% Hospital ---------------------------- 20-50% Unneccesary 80% Community ------------------------------------------------------------------------------------ Agricultural use (50%) 20% Therapeutic --------------------------------- 40-80% Highly 80% Prophylactic/growth questionable. promoation.

  5. GRAM POSITIVES

  6. MRSA IN PAKISTAN

  7. MRSA PAKISTAN • Ghulam Mujtaba Siddiquei, Karamat Ahmed Karamat, Abdul Hannan. PAF Hospital SargodhaPakistan J Pathol. 1999;10(2):26-8. • 372 strains of Staphylococcus aureus were isolated • 1995 / 1996. • 22.3% (MRSA). • This prevalence of MRSA in Pakistan should not go without our serious concern. • Hafiz S, A.Ahmed et al.Methicillin resistant Staphylococcus aureus : a multicentre studyJPMA; 2002;52(7):312-4. • Result: 42% (MRSA) • No Vancomycin resistance was encountered.

  8. MRSA IN LAHORE 4%VRSA? • Nizam Khatoon, Hussain Bukhari S M,et al. (Mayo Hospital Lahore)Biomedica 2002;18:49-52. • 350 positive cultures for Staphylococcus aureus, 135 were found to be methicillin resistant (38.5%). • Mulazim Hussain Bukhari et al. • Mayo Hospital Lahore Pak J Med Sci. 2004;20(3):229-33 • 350 positive S.aureus cultures, 135 were found to be Methicillin resistant (38.5%) • Showed susceptibility 96%, 94% and 86% to Vancomycin, Teicoplanin and Fucidic acid respectively.

  9. MRSA IN KARACHI Dr. Amtul Hafeez, 1994 43% JPMC Dr. Afia Zafar, 2003 40% AKUH Dr. Altaf Ahmed, 2004 36% LNH SALEEM HAFIZ, 2002 42% SIUT

  10. Status of VRSA • No VRSA--Ayaz Hussain Qureshi et al. AMC Rawalpindi, Pak J Med Sci, 2004;20:361-4

  11. Nasal Carriage of MRSA in Pakistan • Muhammad Saeed Anwar, et al.Staphylococcus Aureus and MRSA nasal carriage in general populationJCPSP; 2004;14(11):661-4. • Nasal swabs from 1660 subjects from the community were studied. • 246 (14.82%) samples were positive for growth of S. aureus (nasal carriers of S. aureus). • Out of 246 S. aureus isolates, 48 (19.51%) isolates were (MRSA).

  12. Prevalence of MRSA in Asia Pacific Region 2003/2004

  13. Staphylococcus aureus bacteraemia due to MRSA, by region (England & Wales, 1991- 2003) source: routine laboratory reporting to CDSC

  14. One of the lowest • Denmark has only 0.2% MRSA BMJ 1998; 317:620 WHY?

  15. Trend in Rate of VRE • Tariq Butt et al.Emergence of Vancomycin resistant enterococci faecium in northern Pakistan 2004; 54:275-6. • VRE in LNH :- • 9 CASES, All from nephro • All died • LINEZOLID?

  16. High incidence of penicillin Resistant S. Pneumoniae in R.T.I Japan 54% Spain 65.6% France 66.5 % USA 34.1% % Isolates Results of international surveillance study presented in 15thAasia pacific congress on diseases of the chest Dec 1999

  17. Penicillin resistant Streptococcus pneumoniae, LNH, Karachi- 2005 % Sensitive R I S

  18. ESBLS • EXTENDED SPECTRUM BETA LACTAMASES

  19. Evolution of -Lactamase Plasmid-mediated TEM and SHV Enzymes Third-generation cephalosporins Ampicillin 1980s 1983 1965 1970s 1987 2001 >150 ESBLs worldwide TEM-1 E. coli S. paratyphi TEM-1 Reported in 28 gram-negativespecies ESBL in Europe ESBL inUnitedStates 1963

  20. Some Speciesin which ESBLs are Found • Klebsiella • Escherichia coli • Enterobacter • Proteus • Salmonella • Citrobacter • Pseudomonas • Acinetobacter • and others!!! Numbers are increasing every week Bradford PA. Clin MicrobiolRev. 2001;14:933

  21. Evolution of ß-lactamases No. of enzymes Bush K. Clin Infect Dis 2001;32:1085

  22. Extended Spectrum Beta- Lactamase(ESBL) producing Nosocomial GNRs 30% AKU, Karachi Jabeen K, Zafar A, Hasan R JPMA 2003 37% PIMS, Islamabad Shah A, Hasan F, Ahmed S. Pak J Med Science. 2003 45% AMC, Rawalpindi Rafi A, Qureshi AH. JAMC2003

  23. SLIDE DONATED BY DR. AFIA, AKUH

  24. SLIDE DONATED BY DR.AFIA, AKUH

  25. PAN RESISTANCE,LNH2004 -2005 AcinetobacterPs.aeruginosa Medical ICU 38 14 Surgical ICU 23 08

  26. ESBL Producers usually do not respond to Penicillins, All Cephalosporins and Aztreonam.

  27. TYPHOID • MULTI DRUG RESISTANT TYPHOID • FLOUROQUINOLONE RESISTANT TYPHOID

  28. Ciprofloxacin Treatment Failure in Typhoid Fever Rawalpindi, Pakistan • Tariq Butt, et al.*Armed Forces Institute of Pathology, Rawalpindi, Pakistan • Emerging Infec Dis., 2003; Vol: 9, No. 12 • Inadequacy of the current laboratory guidelines for detection of this resistance. • The spread of this resistance would leave only the less effective but more expensive, third-generation cephalosporins for treatment of typhoid. • Fluoroquinolone resistance must be identified early, and these drugs must be used judiciously. Otherwise, society may be faced with the prospect of untreatable typhoid fever.

  29. LNH Co-trimoxazole Ampicillin Ciprofloxacin Chloramphenicol

  30. Nalidixic acid resistance S.typhi-Rawalpindi Study • 17% of the isolates were resistant to nalidixic acid. • Nalidixic acid disc diffusion and MIC estimation by E-test were 100% comparable. • Isolates which were resistant to nalidixic acid had raised MIC values against Ciprofloxacin. • Anjum P, Qureshi A H, Rafi S. Fluroquinolone resistance in Typhoidal Salmonella and its detection by Nalidixic acid disc diffusionJPMA 2004;54(6):295-301.

  31. Ciprofloxacin MIC by E test MIC ug/ml No % 0.12 2 3 0.19 4 6 0.25 26 39 0.38 19 29 0.50 6 9 0.75 4 6 1.0 4 6 1.5 1 2 E Test Strip LNH STUDY of 200 isolates

  32. Nalidixic acid /Ciprofloxacin-resistant (MIC 1.0) (MIC 0.25)

  33. Multi-drug resistant Tuberculosis in Northern Pakistan, 2004 • Results:325 clinical specimens. • 15% isolates were resistant to a single drug, 28% were multi-drug resistant including 7% which were resistant to all the four drugs. • Rifampicin 32%, isoniazid 37%, streptomycin 19% and ethambutol 17%. • Butt T, Ahmad R N, Kazmi S Y, Rafi N. Multi-drug resistant Tuberculosis in Northern PakistanJPMA 2004;54(9):469-72.

  34. Resistant Tuberculosis in Southern Pakistan1995-2005 Badar F.1995;2:Infec Dis.Soc.Mednews Antibiotic susceptibility report, AKUH IDJ, 2005;14:30.

  35. Thai study • Antimicrobial resistance in the developing world is most likely related to the frequent unrestricted use of over-the-counter drugs without medical supervision. 1 Hoge CW, Gambel JM, Srijan A, et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis 1998;26:341-345.

  36. PROBLEMS OF ANTIBIOTIC THERAPY • 40% of the antibiotics produced each year are used in animals. • Growth enhancers in cattle and poultry • Trout and Salmon farms • As aerosols to fruit trees – sprays from planes – people receiving small but repeated doses of antibiotics Chicken feed heavily loaded with tetracycline

More Related